PP
IDXX icon

PDS Planning’s Idexx Laboratories IDXX Stock Holding History

PDS Planning’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$564K Buy
1,003
+42
+4% +$26.9K 0.04% 242
2025
Q4 		$650K Sell
961
-6
-0.6% -$4.09K 0.04% 209
2025
Q3 		$618K Sell
967
-10
-1% -$6.07K 0.04% 206
2025
Q2 		$524K Buy
977
+336
+52% +$161K 0.04% 226
2025
Q1 		$269K Buy
641
+24
+4% +$10.4K 0.02% 350
2024
Q4 		$255K Buy
617
+14
+2% +$6.14K 0.02% 336
2024
Q3 		$305K Buy
603
+15
+3% +$7.29K 0.03% 291
2024
Q2 		$286K Sell
588
-1
-0.2% -$502 0.03% 265
2024
Q1 		$318K Buy
589
+8
+1% +$4.37K 0.03% 246
2023
Q4 		$322K Buy
581
+26
+5% +$12.2K 0.04% 222
2023
Q3 		$243K Sell
555
-27
-5% -$13.5K 0.03% 249
2023
Q2 		$292K Buy
582
+171
+42% +$81.9K 0.04% 221
2023
Q1 		$206K Buy
+411
New +$197K 0.03% 262

Other funds holding IDXX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

PDS Planning's IDXX Position: Q1 2026 in Review

PDS Planning increased its Idexx Laboratories (IDXX) stake by 4.4% in Q1 2026, buying an estimated $26.9K and bringing the position to 1,003 shares worth $564K. The position accounts for 0.04% of the portfolio, ranked #242.

PDS Planning first reported a position in IDXX in Q1 2023 and has held it in 13 quarters since. The position peaked at $650K in Q4 2025. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • PDS Planning held 1,003 shares of Idexx Laboratories worth $564K as of Q1 2026.
  • PDS Planning bought 42 Idexx Laboratories shares in Q1 2026, an estimated $26.9K.
  • Idexx Laboratories made up 0.04% of PDS Planning's portfolio in Q1 2026, its #242 holding.
  • PDS Planning first reported a position in Idexx Laboratories in Q1 2023 and has held it in 13 quarters since.
  • PDS Planning's Idexx Laboratories position peaked at $650K in Q4 2025.
  • 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on PDS Planning's 13F filing for Q1 2026, filed 22 Apr 2026.